Li M - Search Results

1

[The usefulness of p16INK4a in cytological screening of cervical carcinoma].

Li M, Cao J, Wang NP, Li LY, Li L, Qiao YL, Pan QJ. Li M, et al. Among authors: li ly, li l. Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):674-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274373 Chinese.

2

[Significance of high-risk human papillomavirus DNA in atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion].

Mei P, Liu YH, Li M, Luo XL, Zhuang HG, Luo DL, Lin HH, Zeng RH, Wang XB, Kuang LJ. Mei P, et al. Among authors: li m. Zhonghua Bing Li Xue Za Zhi. 2009 May;38(5):337-9. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19575878 Chinese.

3

ImmunoCyt and cytokeratin 20 immunocytochemistry as adjunct markers for urine cytologic detection of bladder cancer: a prospective study.

Li HX, Li M, Li CL, Ma JH, Wang MR, Rao J, Pan QJ. Li HX, et al. Among authors: li m, li cl. Anal Quant Cytol Histol. 2010 Feb;32(1):45-52. Anal Quant Cytol Histol. 2010. PMID: 20701087

4

[Accuracy of liquid-based cytology in diagnosis of high-grade squamous cervical intraepithelial neoplasia].

Li M, Mei P, Luo DL, Wang XB, Liu YH. Li M, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Apr;41(4):265-8. doi: 10.3760/cma.j.issn.0529-5807.2012.04.011. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22800524 Chinese.

5

[Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].

Li M, Li HX, Guo HQ, Zhao H, Zhao LL, Ma JH, Li CL, Cao J, Pan QJ. Li M, et al. Among authors: li hx, li cl. Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):669-73. doi: 10.3760/cma.j.issn.0253-3766.2012.09.006. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 23159079 Chinese.

6

[Status and prospect of esophageal cancer screening].

Li MJ, Chen R, Wang SM, Wei WW. Li MJ, et al. Zhonghua Zhong Liu Za Zhi. 2025 Jan 23;47(1):94-99. doi: 10.3760/cma.j.cn112152-20231024-00231. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 39828586 Review. Chinese.

7

[Analysis of diagnosis accuracy of frozen sections in 73 cases of borderline tumor of ovary].

Li M, Liu YH, Zhuang HG, Lin HH, Zeng RH, Wang XB, Mei P, Luo DL, Luo XL, Zhang W. Li M, et al. Zhonghua Bing Li Xue Za Zhi. 2009 Feb;38(2):106-9. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19573355 Chinese.

8

Dihydromyricetin Protects Against Hypoxia/Reoxygenation Injury in Cardiomyocytes by Activating miR-34a-Mediated Notch1 Pathway.

Li Y, Li M. Li Y, et al. Among authors: li m. Cardiovasc Toxicol. 2025 Jan 26. doi: 10.1007/s12012-025-09959-5. Online ahead of print. Cardiovasc Toxicol. 2025. PMID: 39864044

9

Repression of PFKFB3 sensitizes ovarian cancer to PARP inhibitors by impairing homologous recombination repair.

Xiao Y, Wu Y, Wang Q, Li M, Deng C, Gu X. Xiao Y, et al. Among authors: li m. Cell Commun Signal. 2025 Jan 25;23(1):48. doi: 10.1186/s12964-025-02056-8. Cell Commun Signal. 2025. PMID: 39863903 Free article.

10

Clinical characteristics, complications and satisfaction of megameatus intact prepuce (MIP) hypospadias variant: a 15 year retrospective study.

He M, Fan S, Sun N, Tian J, Li M, Song H, Zhang W. He M, et al. Among authors: li m. BMC Urol. 2025 Jan 25;25(1):16. doi: 10.1186/s12894-025-01700-2. BMC Urol. 2025. PMID: 39863843 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75,811 results

Search Page

Filters